European Companies Search Engine

EU funding (€15.3M): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised … Hor 1 Apr 2019 EU Research and Innovation programme "Horizon"

Overview

Text

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank. How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.


Funded Companies:

Company name Funding amount
Abbvie Inc. €0.00
Academisch Ziekenhuis Groningen €260,939
Agenzia Regionale Di Sanita €359,110
Alma Mater Studiorum - Universita Di Bologna €832,760
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) €328,420
Bionotus €676,038
Bristol-Myers Squibb Company Corp €0.00
Centre Hospitalier Universitaire de Toulouse €912,929
Centre Hospitalier Universitaire Vaudois €482,806
Consiglio Nazionale Delle Ricerche €143,223
Elevate B.V. €114,919
Eli Lilly and Company Ltd. €0.00
Ellegaard Gottingen Minipigs AS €0.00
European Forum for Good Clinical Practice €71,648
European Institute of Women's Health CLG €135,160
Fundacion para El Fomento de La Investigacion Sanitaria y Biomedica de La Comunitat Valenciana €89,869
Glaxosmithkline Research & Development Ltd. €0.00
Hospices Civils de Lyon €0.00
Institut National de la Sante et de la Recherche Medicale €60,721
Izmir Katip Celebi Universitesi €0.00
Janssen Pharmaceutica N.V. €0.00
Karolinska Institutet €10,266.91
Katholieke Universiteit Leuven €1,062,746
Labcorp Early Development Laboratories Ltd. €0.00
Manchester University NHS Foundation Trust €0.00
Masarykova Univerzita €0.00
Medicines and Healthcare Products Regulatory Agency €60,597
Medizinische Universitat Graz €0.00
Merck KGaA €0.00
Ministry OF Health €0.00
Nearshore Macedonia Ltd. Skopje €0.00
Novartis Pharma AG €0.00
Novo Nordisk A/S €0.00
Orcion B.V. €235,314
Pfizer Ltd. €0.00
PNO Life Sciences & Health B.V. €41,638
Region Stockholm €89,000
Region Syddanmark €0.00
Region Uppsala €96,896
Rijksinstituut Voor Volksgezondheid EN Milieu (Rivm) €107,321
Sanofi-Aventis Recherche & Developpement €0.00
Shamir Health Corporation €0.00
Srebrnjak Children's Hospital €0.00
St George's Hospital Medical School €370,324
Stichting Entis (European Network Teratology Information Services) Foundation €390,862
Stichting Lareb €866,023
Swansea University €187,844
Synergist Services €0.00
Takeda Development Centre Europe Ltd. €0.00
Takeda Pharmaceuticals International AG €0.00
Terveyden JA Hyvinvoinnin Laitos €283,161
Teva Pharmaceutical Industries Ltd. €0.00
THE European Institute for Innovation Through Health Data €446,011
THE European Medicines Agency €33,158
The Newcastle Upon Tyne Hospitals NHS Foundation Trust €602,464
THE Synergist €316,464
The University of Manchester €390,398
UCB Biopharma €0.00
Universita Degli Studi Di Ferrara €238,532
Universitaet Leipzig €0.00
Universitair Medisch Centrum Utrecht €2,486,436
Universite DE Geneve €0.00
Universitetet I Oslo €806,665
University OF Kwazulu-Natal €122,638
University of Ulster €692,410
Uniwersytet Medyczny im Piastow Slaskich WE Wroclawiu €0.00
Uppsala Universitet €894,281

Source: https://cordis.europa.eu/project/id/821520

The filing refers to a past date, and does not necessarily reflect the current state.